Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities
Net income (loss)	$ 7,642,696	$ (15,626,883)
Adjustments to reconcile net income (loss) to net cash used in operating activities
Depreciation and amortization	129,502	1,070,581
Noncash interest expense		1,261,495
Stock compensation expense	558,158	138,168
Change in inventory reserve	(54,830)	535,755
Cash bonus taken in the form of stock compensation		283,554
Gain on impairment adjustment	(2,079,575)
Gain on settlement of compensation expenses	(570,785)
Loss on deconsolidation of subsidiaries	75,138
Change in fair value of derivative liabilities		(65,800)
Change in fair value of EIB loan guaranty	(10,873,867)
Changes in operating assets and liabilities
Accounts receivable	78,915	91,522
Inventory	54,830	290,366
Other assets	98,233	86,516
Accounts payable	(7,281)	399,197
Accrued compensation and other liabilities	337,284	(1,161,958)
Deferred revenue	(25,926)	54,388
Net cash used in operating activities	(4,637,508)	(12,643,099)
Cash flows from investing activities
Purchases of property and equipment		(799,498)
Net cash used in investing activities		(799,498)
Cash flows from financing activities
Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs		10,188,158
Proceeds from issuance of preferred stock, net of issuance costs	2,950,217
Proceeds from issuance of common stock, net of issuance costs	1,988,359
Proceeds from short-term insurance financing	300,926
Payments on short-term insurance financing	(120,371)
Payments on debt		(3,910,010)
Payments on finance lease obligations	(280)	(2,523)
Net cash provided by financing activities	5,118,851	6,275,625
Effects of exchange rates on cash		15,977
Net increase (decrease) in cash and cash equivalents and restricted cash	481,343	(7,150,995)
Cash and cash equivalents and restricted cash at beginning of period	1,454,085	7,935,659
Cash and cash equivalents and restricted cash at end of period	1,935,428	784,664
Supplemental disclosure of cash flow information
Cash paid for interest	4,317	1,422,343
Supplemental disclosures of noncash investing and financing activities
Right-of-use assets acquired through operating leases		801,321
Purchased equipment not yet paid for		94,784
Settlement of deferred compensation and severance	1,333,285
Issuance of common stock upon conversion of preferred stock	$ 2,950,217